Elekta (OTCMKTS:EKTAY) Shares Down 7.3% – Time to Sell?

Elekta AB (OTCMKTS:EKTAY) shares dropped 7.3% on Wednesday . The company traded as low as $4.9050 and last traded at $4.9050. Approximately 1,548 shares changed hands during mid-day trading, a decline of 43% from the average daily volume of 2,709 shares. The stock had previously closed at $5.29.

Wall Street Analysts Forecast Growth

Separately, Zacks Research downgraded Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Elekta Stock Up 1.0%

The company has a debt-to-equity ratio of 0.47, a quick ratio of 0.68 and a current ratio of 0.87. The firm has a market cap of $1.81 billion, a PE ratio of -30.69 and a beta of 1.01. The stock has a fifty day moving average price of $5.59 and a 200-day moving average price of $5.96.

Elekta (OTCMKTS:EKTAY) last posted its earnings results on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The firm had revenue of $521.00 million during the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. Research analysts expect that Elekta AB will post 0.43 EPS for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.